Carlo M. Cicala

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Socioeconomic disparities in sarcoma diagnosis, expert center access, and advocacy group awareness: a multicenter study in Southern Europe.

Socioeconomic disparities in sarcoma diagnosis, expert center access, and advocacy group awareness: a multicenter study in Southern Europe.

Journal: The oncologist
Published: July 23, 2026

Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review.

Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review.

Journal: JAMA oncology
Published: October 16, 2025

Gastrointestinal Stromal Tumor: Current Approaches and Future Directions in the Treatment of Advanced Disease.

Gastrointestinal Stromal Tumor: Current Approaches and Future Directions in the Treatment of Advanced Disease.

Journal: Hematology/oncology clinics of North America
Published: May 14, 2025

Next questions on gastrointestinal stromal tumors: unresolved challenges and future directions.

Next questions on gastrointestinal stromal tumors: unresolved challenges and future directions.

Journal: Current opinion in oncology
Published: April 10, 2025

Emerging treatments for sarcoma: from 2024 onward.

Emerging treatments for sarcoma: from 2024 onward.

Journal: Expert opinion on emerging drugs
Published: January 28, 2025

Targeted Next-Generation Sequencing in Succinate Dehydrogenase-Deficient GI Stromal Tumor Identifies Actionable Alterations in the PI3K/mTOR Pathway.

Targeted Next-Generation Sequencing in Succinate Dehydrogenase-Deficient GI Stromal Tumor Identifies Actionable Alterations in the PI3K/mTOR Pathway.

Journal: JCO precision oncology
Published: January 09, 2025

International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized Disease.

International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized Disease.

Journal: The American journal of surgical pathology
Published: October 28, 2024

Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group.

Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group.

Journal: ESMO open
Published: May 23, 2024

Monitoring advanced gastrointestinal stromal tumor with circulating tumor DNA.

Monitoring advanced gastrointestinal stromal tumor with circulating tumor DNA.

Journal: Current opinion in oncology
Published: May 10, 2024

KIT/PDGFRA inhibitors for the treatment of gastrointestinal stromal tumors: getting to the gist of the problem.

KIT/PDGFRA inhibitors for the treatment of gastrointestinal stromal tumors: getting to the gist of the problem.

Journal: Expert opinion on investigational drugs
Published: February 12, 2024

The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.

The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.

Journal: PloS one
Published: December 27, 2023

Dostarlimab: From preclinical investigation to drug approval and future directions.

Dostarlimab: From preclinical investigation to drug approval and future directions.

Journal: Human vaccines & immunotherapeutics
Published: February 10, 2023
Showing 1-12 of 16

Last Updated: 09/26/2026